These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23709657)

  • 1. Coronary collaterals predict improved survival and allograft function in patients with coronary allograft vasculopathy.
    Lavine KJ; Sintek M; Novak E; Ewald G; Geltman E; Joseph S; Pfeifer J; Mann DL
    Circ Heart Fail; 2013 Jul; 6(4):773-84. PubMed ID: 23709657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early aspirin use and the development of cardiac allograft vasculopathy.
    Kim M; Bergmark BA; Zelniker TA; Mehra MR; Stewart GC; Page DS; Woodcome EL; Smallwood JA; Gabardi S; Givertz MM
    J Heart Lung Transplant; 2017 Dec; 36(12):1344-1349. PubMed ID: 28781013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients.
    Clemmensen TS; Eiskjær H; Løgstrup BB; Ilkjær LB; Poulsen SH
    J Heart Lung Transplant; 2017 May; 36(5):567-576. PubMed ID: 28089194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of coronary flow reserve in heart transplantation: a study performed with contrast-enhanced echocardiography.
    Osto E; Tona F; Angelini A; Montisci R; Ruscazio M; Vinci A; Tarantini G; Ramondo A; Gambino A; Thiene G; Caforio AL; Gerosa G; Iliceto S
    J Heart Lung Transplant; 2009 May; 28(5):453-60. PubMed ID: 19416773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death.
    Hollenberg SM; Klein LW; Parrillo JE; Scherer M; Burns D; Tamburro P; Oberoi M; Johnson MR; Costanzo MR
    Circulation; 2001 Dec; 104(25):3091-6. PubMed ID: 11748106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.
    Luk A; Alba AC; Butany J; Tinckam K; Delgado D; Ross HJ
    Transpl Int; 2015 Jul; 28(7):857-63. PubMed ID: 25778989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
    Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy.
    Coutance G; Ouldamar S; Rouvier P; Saheb S; Suberbielle C; Bréchot N; Hariri S; Lebreton G; Leprince P; Varnous S
    J Heart Lung Transplant; 2015 Aug; 34(8):1050-7. PubMed ID: 25956740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.
    Wu GW; Kobashigawa JA; Fishbein MC; Patel JK; Kittleson MM; Reed EF; Kiyosaki KK; Ardehali A
    J Heart Lung Transplant; 2009 May; 28(5):417-22. PubMed ID: 19416767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients.
    Labarrere CA; Woods JR; Hardin JW; Campana GL; Ortiz MA; Jaeger BR; Baldridge LA; Pitts DE; Kirlin PC
    PLoS One; 2012; 7(4):e36100. PubMed ID: 22558345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy.
    Daud A; Xu D; Revelo MP; Shah Z; Drakos SG; Dranow E; Stoddard G; Kfoury AG; Hammond MEH; Nativi-Nicolau J; Alharethi R; Miller DV; Gilbert EM; Wever-Pinzon O; McKellar SH; Afshar K; Khan F; Fang JC; Selzman CH; Stehlik J
    Circ Heart Fail; 2018 Aug; 11(8):e004759. PubMed ID: 30354559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary microvascular dysfunction correlates with the new onset of cardiac allograft vasculopathy in heart transplant patients with normal coronary angiography.
    Tona F; Osto E; Famoso G; Previato M; Fedrigo M; Vecchiati A; Perazzolo Marra M; Tellatin S; Bellu R; Tarantini G; Feltrin G; Angelini A; Thiene G; Gerosa G; Iliceto S
    Am J Transplant; 2015 May; 15(5):1400-6. PubMed ID: 25766634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejection.
    Rutz T; de Marchi SF; Roelli P; Gloekler S; Traupe T; Steck H; Eshtehardi P; Cook S; Vogel R; Mohacsi P; Seiler C
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1187-94. PubMed ID: 23612502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation.
    Kübrich M; Petrakopoulou P; Kofler S; Nickel T; Kaczmarek I; Meiser BM; Reichart B; von Scheidt W; Weis M
    Transplantation; 2008 Jun; 85(11):1580-7. PubMed ID: 18551063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.
    Paul P; Picard C; Sampol E; Lyonnet L; Di Cristofaro J; Paul-Delvaux L; Lano G; Nicolino-Brunet C; Ravis E; Collart F; Dignat-George F; Dussol B; Sabatier F; Mouly-Bandini A
    Circulation; 2018 Mar; 137(10):1049-1059. PubMed ID: 29097449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study.
    Loupy A; Coutance G; Bonnet G; Van Keer J; Raynaud M; Aubert O; Bories MC; Racapé M; Yoo D; Duong Van Huyen JP; Bruneval P; Taupin JL; Lefaucheur C; Varnous S; Leprince P; Guillemain R; Empana JP; Levine R; Naesens M; Patel JK; Jouven X; Kobashigawa J
    Circulation; 2020 Jun; 141(24):1954-1967. PubMed ID: 32363949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention.
    Agarwal S; Parashar A; Kapadia SR; Tuzcu EM; Modi D; Starling RC; Oliveira GH
    JACC Heart Fail; 2014 Jun; 2(3):281-8. PubMed ID: 24952696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary interventions and bypass surgery in patients with cardiac allograft vasculopathy: a single-center experience.
    Prada-Delgado O; Estévez-Loureiro R; López-Sainz A; Gargallo-Fernández P; Paniagua-Martín MJ; Marzoa-Rivas R; Barge-Caballero E; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG
    Transplant Proc; 2012 Nov; 44(9):2657-9. PubMed ID: 23146485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
    J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.